Jane Street Group, LLC Myriad Genetics Inc Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 121,181 shares of MYGN stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121,181
Previous 101,497 19.39%
Holding current value
$1.62 Million
Previous $2.48 Million 33.6%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$23.97 - $28.6 $471,825 - $562,962
19,684 Added 19.39%
121,181 $3.32 Million
Q2 2024

Aug 14, 2024
BUY
$17.98 - $25.47 $1.2 Million - $1.7 Million
66,711 Added 191.78%
101,497 $2.48 Million
Q1 2024

May 15, 2024
SELL
$17.59 - $23.59 $492,871 - $660,991
-28,020 Reduced 44.61%
34,786 $741,000
Q4 2023

Feb 14, 2024
BUY
$13.91 - $21.32 $295,559 - $453,007
21,248 Added 51.13%
62,806 $1.2 Million
Q3 2023

Nov 14, 2023
SELL
$15.99 - $23.22 $996,704 - $1.45 Million
-62,333 Reduced 60.0%
41,558 $666,000
Q2 2023

Aug 14, 2023
BUY
$17.56 - $23.76 $638,692 - $864,198
36,372 Added 53.87%
103,891 $2.41 Million
Q1 2023

May 15, 2023
BUY
$15.26 - $23.75 $575,988 - $896,443
37,745 Added 126.77%
67,519 $1.57 Million
Q4 2022

Feb 14, 2023
BUY
$14.51 - $20.99 $133,593 - $193,254
9,207 Added 44.77%
29,774 $432,000
Q3 2022

Nov 14, 2022
BUY
$18.21 - $27.88 $374,525 - $573,407
20,567 New
20,567 $392,000
Q2 2022

Aug 16, 2022
SELL
$16.45 - $25.88 $556,240 - $875,106
-33,814 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$22.67 - $28.01 $288,181 - $356,063
12,712 Added 60.24%
33,814 $852,000
Q4 2021

Feb 15, 2022
SELL
$24.13 - $32.63 $2,364 - $3,197
-98 Reduced 0.46%
21,102 $583,000
Q2 2021

Aug 16, 2021
BUY
$25.39 - $32.61 $209,061 - $268,510
8,234 Added 63.5%
21,200 $648,000
Q1 2021

May 18, 2021
SELL
$19.92 - $31.6 $753,334 - $1.2 Million
-37,818 Reduced 74.47%
12,966 $395,000
Q4 2020

Feb 17, 2021
SELL
$12.16 - $19.77 $31,251 - $50,808
-2,570 Reduced 4.82%
50,784 $1.01 Million
Q3 2020

Nov 17, 2020
BUY
$11.25 - $14.75 $132,288 - $173,445
11,759 Added 28.27%
53,354 $696,000
Q2 2020

Aug 17, 2020
BUY
$10.69 - $16.49 $444,650 - $685,901
41,595 New
41,595 $471,000
Q1 2020

May 15, 2020
SELL
$9.78 - $29.53 $209,575 - $632,798
-21,429 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$20.93 - $35.1 $201,325 - $337,626
9,619 Added 81.45%
21,429 $584,000
Q3 2019

Nov 14, 2019
BUY
$22.08 - $47.08 $260,764 - $556,014
11,810 New
11,810 $338,000
Q2 2018

Aug 15, 2018
SELL
$27.75 - $40.17 $287,601 - $416,321
-10,364 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$28.83 - $41.01 $298,794 - $425,027
10,364 New
10,364 $306,000

Others Institutions Holding MYGN

# of Institutions
253
Shares Held
90.5M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.08B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email